Replies to post #94414 on Ayala Pharmaceuticals Inc (ADXS)

[Bourbon_on_my_cornflakes]

Only 2 qtrs cash. Cash raise needed soon.

No deals appearing, major dilution seems inevitable.

$10 million net from AMGN helped reduce the burn a little. Too bad NEO was cancelled by AMGN, would almost be break even if program has kept going with AMGN

[raja48185]

Quote:ADXS should have around 4 quarters of cash on hand, based on $44M.


That's an old data, from 10/31/2018.

Going by the PR, the expenses for fiscal Q1 2019 should be taken care of by the one time earnings of 12 million. So cash status should remain almost same as the Q4 fiscal 2018 (+ / - a couple of million)